SK Bioscience Co. on Thursday reported its fourth-quarter net income of 4.2 billion won (US$3.1 million), down 85 percent from a year earlier.The company said in a regulatory filing that it posted an operating loss of 8.4 billion won for the October-December period, compared with a profit of 8.7 billion won a year ago. Revenue fell 35.4 percent to 90.6 billion won.(END)Source: Yonhap News Agency
Recent Posts
Middle East Crisis Deepens Global Hunger and Inflation
April 20, 2026
Myanmar Clears Path for Junta Leader to Become President
March 30, 2026
Myanmar Junta Chief Min Aung Hlaing Nominated as President
March 29, 2026
Maternal Deaths Surge in Conflict Zones, WHO Report Reveals
February 17, 2026
Cambodia Seeks French Intervention in Border Dispute with Thailand
February 16, 2026